| Literature DB >> 20832755 |
Mark E Hatley1, David M Patrick, Matthew R Garcia, James A Richardson, Rhonda Bassel-Duby, Eva van Rooij, Eric N Olson.
Abstract
Lung cancer is the leading cause of cancer-related deaths in the world, and non-small-cell lung cancer (NSCLC) accounts for 80% of cases. MicroRNA-21 (miR-21) expression is increased and predicts poor survival in NSCLC. Although miR-21 function has been studied in vitro with cancer cell lines, the role of miR-21 in tumor development in vivo is unknown. We utilize transgenic mice with loss-of-function and gain-of-function miR-21 alleles combined with a model of NSCLC to determine the role of miR-21 in lung cancer. We show that overexpression of miR-21 enhances tumorigenesis and that genetic deletion of miR-21 partially protects against tumor formation. MiR-21 drives tumorigenesis through inhibition of negative regulators of the Ras/MEK/ERK pathway and inhibition of apoptosis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20832755 PMCID: PMC2971666 DOI: 10.1016/j.ccr.2010.08.013
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743